Department of Psychiatry, 7938University of Toronto, Ontario, Canada.
7978Centre for Addictions and Mental Health (CAMH), Toronto, Ontario, Canada.
Can J Psychiatry. 2021 Feb;66(2):126-138. doi: 10.1177/0706743720952251. Epub 2020 Sep 10.
Cannabis use is proposed as a risk factor for psychosis and is associated with depressive disorders. However, the relationship between recreational cannabis use and its longitudinal implications on anxiety conditions is less studied. The aim of this investigation is to systematically evaluate published literature and perform a meta-analysis of the data.
A systematic search was performed of MEDLINE, Embase, and PsychINFO from inception to May 31, 2020, in addition to a hand search. Longitudinal studies that evaluated the relationship of cannabis use and development of anxiety were included. Where applicable, adjusted odds ratios () were extracted, pooled, and evaluated using random-effects meta-analysis.
After screening of unique abstracts ( = 6835), the final evaluation included 24 studies, of which 10 reported s that were analyzed quantitatively. Cannabis use was significantly associated with increased odds of developing any anxiety conditions ( = 1.25; 95% CI, 1.01 to 1.54). Cannabis use was not significantly associated with developing generalized anxiety disorder, panic disorder, or social anxiety disorder. Review of studies not reporting revealed mixed results but are suggestive of a link between cannabis use and increased rates/severity of anxiety.
Published evidence suggests that cannabis use is likely associated with increased risk of anxiety in the long term but variability of study designs precludes declaration of a causal relationship. Awareness of this association is of relevance for both clinical practice and mental health policy implementation.
大麻使用被认为是精神病的一个风险因素,并与抑郁障碍有关。然而,娱乐性大麻使用与其对焦虑症的纵向影响之间的关系研究较少。本研究旨在系统评估已发表的文献,并对数据进行荟萃分析。
从 2020 年 5 月 31 日开始,对 MEDLINE、Embase 和 PsychINFO 进行了系统检索,并进行了手工检索。纳入了评估大麻使用与焦虑症发展之间关系的纵向研究。在适用的情况下,提取并汇总调整后的优势比(ORs),并使用随机效应荟萃分析进行评估。
在筛选独特的摘要(n=6835)后,最终评估包括 24 项研究,其中 10 项报告了定量 ORs。大麻使用与任何焦虑症发生的几率增加显著相关(OR=1.25;95%CI,1.01 至 1.54)。大麻使用与广泛性焦虑障碍、惊恐障碍或社交焦虑障碍无关。未报告 ORs 的研究回顾显示结果不一,但提示大麻使用与焦虑发生率/严重程度增加之间存在关联。
已发表的证据表明,大麻使用可能与长期焦虑风险增加有关,但研究设计的变异性排除了因果关系的声明。了解这种关联对于临床实践和精神卫生政策的实施都很重要。